Unless you have no TV or Internet, you’ve likely heard of the GLP-1 craze – glossy commercials and ads featuring people ...

Ozempic, Zepbound, Wegovy, and other GLP-1 medications have transformed the way we lose weight. People who take them report life-changi ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story UnitedHealth CEO blames drug companies ...

New data suggest Restylane Lyft or Contour in combination with Sculptra corrects contour deficiencies in patients experiencing facial volume loss following medication-driven weight loss, according to ...

A new report says only using BMI to determine if a patient has obesity leads to under-diagnosing people who are ill and ...

The GLP-1 [glucagon-like peptide 1] agents are poised to become viable options for treating indications beyond type 2 ...

In his first public comments since one of his executives was shot to death, UnitedHealth Group CEO Andrew Witty said the ...

At the J.P. Morgan Health Care conference, the future outlook for GLP-1 drugs used to treat obesity was a key focus, ...

In an investor call, Andrew Witty promised full transparency and 100% pass-through rebates for prescription drugs by 2028.

This is just a glimpse of the insights available to CivicScience clients. Want to see the full picture? Let’s talk. As the ...

Professor Joseph Balagtas explained how drugs like Ozempic impact appetite. Purdue’s Center for Food Demand Analysis and ...

In its first financial results since its insurance unit CEO was fatally shot in New York City, UnitedHealth Group reported ...